ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $36,994,000 | +5689.4% | 214,959 | +4121.5% | 0.13% | +4333.3% |
| Q2 2021 | $639,000 | +161.9% | 5,092 | +182.9% | 0.00% | +50.0% |
| Q1 2021 | $244,000 | -39.5% | 1,800 | -42.9% | 0.00% | 0.0% |
| Q4 2020 | $403,000 | -88.9% | 3,155 | -90.2% | 0.00% | -90.0% |
| Q3 2020 | $3,624,000 | +377.5% | 32,200 | +304.3% | 0.02% | +300.0% |
| Q2 2020 | $759,000 | +94.6% | 7,965 | +83.8% | 0.01% | +150.0% |
| Q1 2020 | $390,000 | +27.0% | 4,334 | -25.3% | 0.00% | 0.0% |
| Q4 2019 | $307,000 | +29.0% | 5,800 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $238,000 | -67.4% | 5,800 | -63.1% | 0.00% | -60.0% |
| Q1 2019 | $731,000 | +28.9% | 15,713 | +20.7% | 0.01% | +25.0% |
| Q4 2018 | $567,000 | -58.4% | 13,016 | -45.3% | 0.00% | -50.0% |
| Q3 2018 | $1,362,000 | +274.2% | 23,800 | +155.9% | 0.01% | +300.0% |
| Q1 2018 | $364,000 | -79.9% | 9,300 | -78.3% | 0.00% | -77.8% |
| Q4 2017 | $1,815,000 | – | 42,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 2,803,645 | $84,782,000 | 78.57% |
| Cormorant Asset Management, LP | 400,000 | $12,096,000 | 2.49% |
| Deer VII & Co. Ltd. | 175,075 | $5,294,000 | 2.36% |
| QVT Financial LP | 1,193,258 | $36,084,000 | 1.86% |
| Foresite Capital Management I, LLC | 55,767 | $1,686,000 | 1.62% |
| Perceptive Advisors | 445,000 | $13,457,000 | 1.44% |
| SECTORAL ASSET MANAGEMENT INC | 726,424 | $21,967,000 | 0.92% |
| Iguana Healthcare Management, LLC | 25,000 | $756,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $3,024,000 | 0.37% |
| Eventide Asset Management | 62,100 | $1,878,000 | 0.26% |